Celera Q2 Revenues Soar; New Research Agreement Signed | GenomeWeb

NEW YORK, Jan 25 –- Celera said Thursday its second quarter fiscal 2001revenues surged to $20.3 million from $8.3 million in the year-ago period as the company continued to rack up one new commercial and three new academic subscribers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.